OrganaBio

OrganaBio was founded in 2018 with the mission to become the hub for tissue sourcing, clinical sample processing and contract manufacturing services to support cell and gene therapy developers around the globe. At our core, we continually apply a data-driven approach with meaningful insights across our strategically located facilities to provide solutions to our clients where they need it most. Headquartered in Miami, Florida, OrganaBio delivers products and services that span the full development lifecycle from proprietary tissue supply chains and cellular starting materials to expert development, testing, and other support services that expedite the path to clinical translation

Cell therapy,regenerative medicine,pbmc,leukopacs,cgmp,immunotherapy,cancer research,cdmo,clinical trial support,cell isolation,and cryopreservation

Organabio operates in the Biotechnology research industry.

Organabio's revenue is 11m - 100m

Organabio has 11 - 50 employees.